2018
DOI: 10.1016/j.pt.2018.07.001
|View full text |Cite
|
Sign up to set email alerts
|

Antimalarial Transmission-Blocking Interventions: Past, Present, and Future

Abstract: Malaria remains a major global health challenge. Appropriate use of current antimalarial tools has reduced the disease burden, but morbidity and mortality remain unacceptably high. It is widely accepted that, to achieve long-term control/eradication, it will be necessary to use interventions that inhibit the transmission of parasites to mosquitoes - these tools are termed transmission-blocking interventions (TBIs). This article aims to outline the rationale for the development of TBIs, with a focus on transmis… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
57
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(65 citation statements)
references
References 123 publications
0
57
0
Order By: Relevance
“…Molecules/pathways involved in these crucial steps of the parasite life cycle may represent novel promising targets for effective transmission-blocking interventions (11).…”
Section: Introductionmentioning
confidence: 99%
“…Molecules/pathways involved in these crucial steps of the parasite life cycle may represent novel promising targets for effective transmission-blocking interventions (11).…”
Section: Introductionmentioning
confidence: 99%
“…With the move towards malaria elimination and eradication, new tools and strategies to reduce onward transmission of Plasmodium infections, including transmission-blocking interventions (TBI), are considered highly beneficial [1,2]. An increasing number of drugand vaccine-based TBI are in the pipeline [3] and will require monitoring tools for efficacy. Additionally, it is considered highly beneficial to characterize the human infectious reservoir for malaria in low endemic settings approaching elimination, to better target and monitor TBI [4,5].…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, the two drugs are beset by toxicity concerns in patients with Glucose-6-phosphate dehydrogenase (G6PD) enzyme deficiency. 18 The above described scenarios, therefore, warrant sustained efforts in the discovery and development of new antimalarial drugs as suitable alternatives to currently existing ones and having transmission-blocking potential.…”
Section: Introductionmentioning
confidence: 99%